Cover Image
市場調查報告書

靜脈血栓症:全球臨床實驗檢討

Venous (Vein) Thrombosis Global Clinical Trials Review, H2, 2014

出版商 GlobalData 商品編碼 316093
出版日期 內容資訊 英文 193 Pages
訂單完成後即時交付
價格
Back to Top
靜脈血栓症:全球臨床實驗檢討 Venous (Vein) Thrombosis Global Clinical Trials Review, H2, 2014
出版日期: 2014年09月30日 內容資訊: 英文 193 Pages
簡介

本報告提供靜脈血栓症的臨床試驗相關之基本資料和數據,為您彙整實驗數量及受驗者的募集情況,各階段趨勢,進行臨床試驗的主要製藥企業及研究機關簡介等資訊。

簡介

  • 靜脈血栓症
  • 本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 亞太地區主要5個國家的臨床實驗數量
    • 歐洲主要5個國家的臨床實驗數量
    • 北美主要國家的臨床實驗數量
    • 中東·非洲的主要5個國家臨床實驗數量
    • 中南美的主要5個國家臨床實驗數量

G7各國臨床實驗數量:心血管疾病治療藥臨床實驗中,靜脈血栓症治療藥所佔的比例

G7各國的各階段臨床實驗數量

G7各國臨床實驗數量:各進展狀況

E7各國臨床實驗數量:靜脈血栓症治療藥的心血管疾病治療藥臨床實驗中,比率

E7各國的各階段臨床實驗數量

E7各國臨床實驗數量:各進展狀況

各階段臨床實驗數量

  • 進行中的臨床實驗:各階段

各進展狀況臨床實驗數量

臨床實驗的目標達成情形

未完成的臨床實驗數量

一定期間所採用的實驗對像

贊助商類別的臨床實驗數量

有潛力的贊助商

參與靜脈血栓症治療藥臨床實驗的主要企業

有潛力的藥劑

臨床實驗簡介

  • 主要企業臨床實驗概要
    • Bayer AG
    • C. H. Boehringer Sohn AG & Co. KG
    • GlaxoSmithKline plc
    • Pfizer Inc.
    • Sanofi
    • Bristol-Myers Squibb Company
    • 第一三共
    • The LEO Foundation
    • AstraZeneca PLC
    • Astellas Pharma Inc.
  • 有代表性的研究機關·醫院臨床實驗概要
    • Brigham and Women's Hospital
    • Ottawa Hospital Research Institute
    • Academic Medical Center
    • Hamilton Health Sciences
    • McMaster University
    • University of Vermont
    • St. Orsola Hospital
    • Washington University School of Medicine
    • Centre Hospitalier Universitaire de Saint Etienne
    • Azienda Ospedaliera Universitaria Policlinico catania

5個有代表性的臨床實驗簡介

附錄

目錄

GlobalData's clinical trial report, "Venous (Vein) Thrombosis Global Clinical Trials Review, H2, 2014" provides data on the Venous (Vein) Thrombosis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Venous (Vein) Thrombosis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Venous (Vein) Thrombosis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Venous (Vein) Thrombosis
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Five Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Five Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Venous (Vein) Thrombosis to Cardiovascular Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Venous (Vein) Thrombosis to Cardiovascular Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Venous (Vein) Thrombosis
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Venous (Vein) Thrombosis Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Bayer AG
      • Clinical Trial Overview of Bayer AG
      • C. H. Boehringer Sohn AG & Co. KG
      • Clinical Trial Overview of C. H. Boehringer Sohn AG & Co. KG
      • GlaxoSmithKline plc
      • Clinical Trial Overview of GlaxoSmithKline plc
      • Pfizer Inc.
      • Clinical Trial Overview of Pfizer Inc.
      • Sanofi
      • Clinical Trial Overview of Sanofi
      • Bristol-Myers Squibb Company
      • Clinical Trial Overview of Bristol-Myers Squibb Company
      • Daiichi Sankyo Company, Limited
      • Clinical Trial Overview of Daiichi Sankyo Company, Limited
      • The LEO Foundation
      • Clinical Trial Overview of The LEO Foundation
      • AstraZeneca PLC
      • Clinical Trial Overview of AstraZeneca PLC
      • Astellas Pharma Inc.
      • Clinical Trial Overview of Astellas Pharma Inc.
    • Clinical Trial Overview of Top Institutes / Government
      • Brigham and Women's Hospital
      • Clinical Trial Overview of Brigham and Women's Hospital
      • Ottawa Hospital Research Institute
      • Clinical Trial Overview of Ottawa Hospital Research Institute
      • Academic Medical Center
      • Clinical Trial Overview of Academic Medical Center
      • Hamilton Health Sciences
      • Clinical Trial Overview of Hamilton Health Sciences
      • McMaster University
      • Clinical Trial Overview of McMaster University
      • University of Vermont
      • Clinical Trial Overview of University of Vermont
      • St. Orsola Hospital
      • Clinical Trial Overview of St. Orsola Hospital
      • Washington University School of Medicine
      • Clinical Trial Overview of Washington University School of Medicine
      • Centre Hospitalier Universitaire de Saint Etienne
      • Clinical Trial Overview of Centre Hospitalier Universitaire de Saint Etienne
      • Azienda Ospedaliera Universitaria Policlinico catania
      • Clinical Trial Overview of Azienda Ospedaliera Universitaria Policlinico catania
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Venous (Vein) Thrombosis Therapeutics, Global, Clinical Trials by Region, 2014*
  • Venous (Vein) Thrombosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Venous (Vein) Thrombosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Venous (Vein) Thrombosis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014*
  • Venous (Vein) Thrombosis Therapeutics Clinical Trials, Europe, Top Five Countries, 2014*
  • Venous (Vein) Thrombosis Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Venous (Vein) Thrombosis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2014*
  • Venous (Vein) Thrombosis Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2014*
  • Proportion of Venous (Vein) Thrombosis to Cardiovascular Clinical Trials, G7 Countries (%), 2014*
  • Venous (Vein) Thrombosis Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Venous (Vein) Thrombosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Venous (Vein) Thrombosis to Cardiovascular Clinical Trials, E7 Countries (%), 2014*
  • Venous (Vein) Thrombosis Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Venous (Vein) Thrombosis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Venous (Vein) Thrombosis Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Venous (Vein) Thrombosis Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • Venous (Vein) Thrombosis Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Venous (Vein) Thrombosis Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Venous (Vein) Thrombosis Therapeutics, Global, Suspended Clinical Trials, 2014*
  • Venous (Vein) Thrombosis Therapeutics, Global, Withdrawn Clinical Trials, 2014*
  • Venous (Vein) Thrombosis Therapeutics, Global, Terminated Clinical Trials, 2014*
  • Venous (Vein) Thrombosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Venous (Vein) Thrombosis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Venous (Vein) Thrombosis Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Venous (Vein) Thrombosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Venous (Vein) Thrombosis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Venous (Vein) Thrombosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2014*
  • Venous (Vein) Thrombosis Therapeutics Clinical Trials Market, Global, Clinical Trials by C. H. Boehringer Sohn AG & Co. KG, 2014*
  • Venous (Vein) Thrombosis Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2014*
  • Venous (Vein) Thrombosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014*
  • Venous (Vein) Thrombosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2014*
  • Venous (Vein) Thrombosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Bristol-Myers Squibb Company, 2014*
  • Venous (Vein) Thrombosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Daiichi Sankyo Company, Limited, 2014*
  • Venous (Vein) Thrombosis Therapeutics Clinical Trials Market, Global, Clinical Trials by The LEO Foundation, 2014*
  • Venous (Vein) Thrombosis Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2014*
  • Venous (Vein) Thrombosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Astellas Pharma Inc., 2014*
  • Venous (Vein) Thrombosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Brigham and Women's Hospital, 2014*
  • Venous (Vein) Thrombosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Ottawa Hospital Research Institute, 2014*
  • Venous (Vein) Thrombosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Academic Medical Center, 2014*
  • Venous (Vein) Thrombosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Hamilton Health Sciences, 2014*
  • Venous (Vein) Thrombosis Therapeutics Clinical Trials Market, Global, Clinical Trials by McMaster University, 2014*
  • Venous (Vein) Thrombosis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Vermont, 2014*
  • Venous (Vein) Thrombosis Therapeutics Clinical Trials Market, Global, Clinical Trials by St. Orsola Hospital, 2014*
  • Venous (Vein) Thrombosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Washington University School of Medicine, 2014*
  • Venous (Vein) Thrombosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Centre Hospitalier Universitaire de Saint Etienne, 2014*
  • Venous (Vein) Thrombosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Azienda Ospedaliera Universitaria Policlinico catania, 2014*

List of Figures

  • Venous (Vein) Thrombosis Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Venous (Vein) Thrombosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Venous (Vein) Thrombosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Venous (Vein) Thrombosis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014*
  • Venous (Vein) Thrombosis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014*
  • Venous (Vein) Thrombosis Therapeutics Clinical Trials, North America, Top Countries (%), 2014*
  • Venous (Vein) Thrombosis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2014*
  • Venous (Vein) Thrombosis Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2014*
  • Proportion of Venous (Vein) Thrombosis to Cardiovascular Clinical Trials, G7 Countries (%), 2014*
  • Venous (Vein) Thrombosis Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Venous (Vein) Thrombosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Venous (Vein) Thrombosis to Cardiovascular Clinical Trials, E7 Countries (%), 2014*
  • Venous (Vein) Thrombosis Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Venous (Vein) Thrombosis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Venous (Vein) Thrombosis Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Venous (Vein) Thrombosis Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • Venous (Vein) Thrombosis Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Venous (Vein) Thrombosis Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Venous (Vein) Thrombosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Venous (Vein) Thrombosis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Venous (Vein) Thrombosis Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Venous (Vein) Thrombosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Venous (Vein) Thrombosis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • GlobalData Methodology
Back to Top